Quoted from http://www.newsobserver.com/business/story/1688217.html
GSK guards pill's image amid probe
Diet pill sales have taken a hitBY MATTHEW PERRONE - The Associated Press
Mon, Sep. 14, 2009 02:00AM
WASHINGTON -- British drug maker GlaxoSmithKline is scrambling to shore up the safety image of its weight loss pill alli after watching sales dive on news that federal regulators are investigating the drug.
Alli has received a high-profile marketing push as the first over-the-counter weight loss medication, complete with television ads and a celebrity endorsement from country singer Wynonna Judd.
However, GSK has spent the last two weeks on damage control after the Food and Drug Administration said it was probing more than 30 reports of liver damage in patients taking alli and Xenical, the prescription version of the drug.
GSK executives say sales of alli dropped 10 percent after the Aug. 24 announcement, even though the FDA stressed it had established no direct link between the drug and liver problems.
GSK rushed out print advertisements in national newspapers and magazines, stressing the extensive safety testing behind the drug....